FindTrial
Sign In

A multicenter prospective randomized controlled trial for the safety of intraoperative salvaged blood in the spinal metastasis surgery

A multicenter prospective randomized controlled trial for the safety of intraoperative salvaged blood in the spinal metastasis surgery

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1800018118
Enrollment
Unknown
Registered
2018-08-31
Start date
2018-10-01
Completion date
Unknown
Last updated
2018-09-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

spinal metastasis

Interventions

Group 1:allogenetic transfusion
Group 2:autotransfusion

Sponsors

Zhongshan Hospital, Fudan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 85 Years

Inclusion criteria

Inclusion criteria: 1. Metastatic tumors of the spine from epithelial origin; 2. Spinal instability; and/or spinal nerve compression, progressive neurological impairment; and/or refractory pain ineffective after conservative treatment; 3. modified Tokuhashi score?9; 4. age<75 years, intraoperative Hb<90 g/L.

Exclusion criteria

Exclusion criteria: 1. Metastatic tumors of the spinal cord from non epithelial origin 2. Spinal primary tumors 3. Expected lifetime less than 6 months; 4. Cardiopulmonary dysfunction.

Design outcomes

Primary

MeasureTime frame
occurance of new lesions;—

Secondary

MeasureTime frame
Incidence of transfusion related adverse reactions;—

Countries

China

Contacts

Public ContactDong Jian

Zhongshan Hospital, Fudan University

15921743533@163.com+86 13916930859

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026